DeepMed Research

Ancora Heart, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study

Not Applicable

Recruiting

Conditions: Heart Failure with Reduced Ejection Fraction (HFrEF)
Dilated Cardiomyopathy

Interventions: Device: AccuCinch Ventricular Restoration System
Drug: Guideline-Directed Medical Therapy

First Posted Date: 2020-04-02

Last Posted Date: 2024-11-11

Lead Sponsor: Ancora Heart, Inc.

Target Recruit Count: 400

Registration Number: NCT04331769

Locations: 🇺🇸
Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, United States
🇩🇪
Immanuel Klinikum Bernau Herzzentrum Brandenburg Universitätsklinikum der Medizinischen Hochschule Brandenburg, Bernau, Germany
🇩🇪
CardioVasculäres Centrum, Frankfurt, Germany

and more 125 locations

Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation

Not Applicable

Completed

Conditions: Cardiomyopathy, Dilated
Heart Failure

Interventions: Device: AccuCinch® Ventricular Restoration System

First Posted Date: 2018-06-18

Last Posted Date: 2024-08-16

Lead Sponsor: Ancora Heart, Inc.

Target Recruit Count: 5

Registration Number: NCT03560167

Locations: 🇺🇸
Minneapolis Heart Foundation Institute, Minneapolis, Minnesota, United States
🇺🇸
Baylor College of Medicine St. Luke's Medical Center, Houston, Texas, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 16 locations

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

Not Applicable

Active, not recruiting

Conditions: Heart Failure
Cardiomyopathy, Dilated

Interventions: Device: AccuCinch® Ventricular Restoration

First Posted Date: 2018-05-23

Last Posted Date: 2025-01-30

Lead Sponsor: Ancora Heart, Inc.

Target Recruit Count: 22

Registration Number: NCT03533517

Locations: 🇺🇸
Carilion Roanoke Memorial, Roanoke, Virginia, United States
🇺🇸
University of Virginia School of Medicine, Charlottesville, Virginia, United States
🇺🇸
Minneapolis Heart Foundation Institute, Minneapolis, Minnesota, United States

and more 15 locations

Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study

Not Applicable

Active, not recruiting

Conditions: Heart Failure
Cardiomyopathies

First Posted Date: 2017-06-12

Last Posted Date: 2025-01-29

Lead Sponsor: Ancora Heart, Inc.

Target Recruit Count: 132

Registration Number: NCT03183895

Locations: 🇮🇹
IRCCS Policlinico San Donato, Milano, Piazza Edmondo Malan, 1 San Donato Milanese,, Italy
🇧🇪
Onze Lieve Vrouwziekenhuis, Aalst, Aaslt, Belgium
🇨🇿
Na Homolce Hospital, Prague, Czechia

and more 16 locations

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Not Applicable

Completed

Conditions: Heart Failure
Cardiomyopathies
Mitral Valve Insufficiency

Interventions: Device: Mitral valve repair

First Posted Date: 2016-06-20

Last Posted Date: 2025-01-29

Lead Sponsor: Ancora Heart, Inc.

Target Recruit Count: 35

Registration Number: NCT02806570

Locations: 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States
🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States
🇺🇸
Minneapolis Heart Foundation Institute, Minneapolis, Minnesota, United States

and more 13 locations

Safety and Performance of the AccuCinch® System

Not Applicable

Withdrawn

Conditions: Heart Failure
Mitral Valve Insufficiency

Interventions: Device: Accucinch Implant

First Posted Date: 2015-12-09

Last Posted Date: 2018-07-27

Lead Sponsor: Ancora Heart, Inc.

Registration Number: NCT02624960

Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function

Not Applicable

Completed

Conditions: Severe Functional Mitral Regurgitation and Heart Failure

Interventions: Device: GDS Accucinch System

First Posted Date: 2014-06-03

Last Posted Date: 2018-05-17

Lead Sponsor: Ancora Heart, Inc.

Target Recruit Count: 2

Registration Number: NCT02153892

Locations: 🇦🇺
Monash Health, Melbourne, Victoria, Australia

Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function

Not Applicable

Completed

Conditions: Functional Mitral Regurgitation

Interventions: Device: AccuCinch® Ventriculoplasty System

First Posted Date: 2013-07-15

Last Posted Date: 2017-06-08

Lead Sponsor: Ancora Heart, Inc.

Target Recruit Count: 8

Registration Number: NCT01899573

Locations: 🇨🇴
Clinica CardioVID, Medellin, Colombia

A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study

Not Applicable

Completed

Conditions: Mitral Regurgitation
Functional Mitral Regurgitation
Mitral Valve Regurgitation

Interventions: Device: AccuCinch® Ventriculoplasty System

First Posted Date: 2008-12-01

Last Posted Date: 2021-07-29

Lead Sponsor: Ancora Heart, Inc.

Target Recruit Count: 16

Registration Number: NCT00800046

Locations: 🇱🇹
Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
🇩🇪
Medical Care Center Hamburg University Cardiovascular Center, Hamburg, Germany
🇩🇪
University Hospital Freiburg-Bad Krozingen, Bad Krozingen, Germany

and more 5 locations

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy